Table 5 WHO/INRUD core drug use indicators in different countries
Country [Ref] | Type of survey, Year | WHO/INRUD Core Drug use Indicators (WHO recommended value) | ||||||
|---|---|---|---|---|---|---|---|---|
Prescribing Indictors | Patient Care Indicators | |||||||
Medicines* (1.6–1.8) | Antibiotics†(20–26.8%) | Injections‡ (13.4–24.1%) | Generic name¥ (100%) | Essential Medicines¶ (100%) | Dispensed# (100%) | Labelled§ (100%) | ||
Sri Lanka | Present study, 2015 | 3.1 | 23.8% | 1.2% | 35.5% | 68.8% | 92.4% | 98.5% |
Africa | Region (PC), 2006–2015 | 3.5 | 49.0% | 24.8% | 70.4% | 88.9% | NR | NR |
Bahrain | PC, 2003 | 2.6 | 26.2% | 8.3% | 14.3% | 99.8% | NR | NR |
Brazil | National (PC), 2015 | 2.4 | 5.8% | 6.0% | NR | 45.1% | NR | NR |
China | Provincial (PC), 2009–2010 | 3.2 | 50.9% | 24.4% | NR | 68.3% | NR | NR |
Jordan | PC, 1999–2000 | 2.3 | 60.9% | 1.2% | 5.1% | 93.0% | 81.8% | 91.4% |
Pakistan | PC, 2014 | 3.4 | 48.9% | 27.1% | 71.6% | 93.4% | 90.9% | 100% |
Saudi Arabia | PC, 2010 | 2.4 | 32.2% | 2.0% | 61.2% | 99.2% | 99.6% | 10.0% |